BACKGROUND: Since 2006 Human papillomavirus (HPV) vaccination has become
available to adolescent girls and women in an increasing number of countries, to protect …

Immunization is the most successful method in preventing and controlling infectious
diseases, which has helped saving millions of lives worldwide. The discovery of the human …

The availability of prophylactic human papillomavirus (HPV) vaccines has provided powerful
tools for primary prevention of cervical cancer and other HPV-associated diseases. Since …

Background Introduction of human papillomavirus (HPV) vaccination in settings with the
highest burden of HPV is not universal, partly because of the absence of quantitative …

Background Our objectives were to describe Human Papillomavirus vaccination coverage
rates (HPV-VCR), policies, and practical steps for programme implementation that may be …

Background Since the introduction of HPV vaccines, several studies have been conducted
in different countries to assess HPV knowledge and vaccine acceptance. The aim of this …

Abstract Background: Human Papillomavirus (HPV) is a common sexually transmitted
infection and is aetiologically linked with a number of health problems. In Germany, HPV …

Las infecciones de transmisión sexual (ITS) comprenden un grupo de patologías, de
etiología infecciosa diversa, en las que la transmisión sexual es relevante desde el punto de …

Human papillomavirus (HPV) is the causative agent in cervical cancer and has been
implicated in a range of other malignancies. Preventative vaccines are now internationally …

American Society of Clinical Oncology (ASCO), the leading medical professional oncology
society, is committed to lessening the burden of cancer and as such will promote underused …